{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:00:07Z","timestamp":1792112407594,"version":"4.4.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.bbr.2008.09.040","type":"journal-article","created":{"date-parts":[[2008,10,14]],"date-time":"2008-10-14T21:54:43Z","timestamp":1224021283000},"page":"168-179","source":"Crossref","is-referenced-by-count":378,"title":["Minocycline and neurodegenerative diseases"],"prefix":"10.1016","volume":"196","author":[{"given":"Hye-Sun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo-Hun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2008.09.040_bib1","first-page":"1061","article-title":"Pharmacotherapeutics of the newer tetracyclines","volume":"176","author":"Aronson","year":"1980","journal-title":"J Am Vet Med Assoc"},{"issue":"1","key":"10.1016\/j.bbr.2008.09.040_bib2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.expneurol.2008.01.022","article-title":"Combined treatment with atorvastatin and minocycline suppresses severity of EAE","volume":"211","author":"Luccarini","year":"2008","journal-title":"Exp Neurol"},{"issue":"12","key":"10.1016\/j.bbr.2008.09.040_bib3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1474-4422(04)00937-8","article-title":"The promise of minocycline in neurology","volume":"3","author":"Yong","year":"2004","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.bbr.2008.09.040_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.bbr.2008.09.040_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neulet.2004.05.038","article-title":"Minocycline suppresses hypoxic activation of rodent microglia in culture","volume":"366","author":"Suk","year":"2004","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.bbr.2008.09.040_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0025-7125(16)30039-6","article-title":"Tetracyclines","volume":"79","author":"Klein","year":"1995","journal-title":"Med Clin North Am"},{"issue":"2","key":"10.1016\/j.bbr.2008.09.040_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2133.2003.05497.x","article-title":"Minocycline stain devil?","volume":"149","author":"Good","year":"2003","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.bbr.2008.09.040_bib8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/1073858405275175","article-title":"Minocycline as a neuroprotective agent","volume":"11","author":"Stirling","year":"2005","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bbr.2008.09.040_bib9","doi-asserted-by":"crossref","first-page":"13496","DOI":"10.1073\/pnas.96.23.13496","article-title":"A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window","volume":"96","author":"Yrjanheikki","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.bbr.2008.09.040_bib10","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1227\/00006123-200106000-00051","article-title":"Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction","volume":"48","author":"Sanchez","year":"2001","journal-title":"Neurosurgery"},{"issue":"6884","key":"10.1016\/j.bbr.2008.09.040_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/417074a","article-title":"Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice","volume":"417","author":"Zhu","year":"2002","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbr.2008.09.040_bib12","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.bbr.2008.09.040_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neulet.2006.01.027","article-title":"Minocycline inhibits caspase-dependent and -independent cell death pathways and is neuroprotective against hippocampal damage after treatment with kainic acid in mice","volume":"398","author":"Heo","year":"2006","journal-title":"Neurosci Lett"},{"issue":"7","key":"10.1016\/j.bbr.2008.09.040_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/77528","article-title":"Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease","volume":"6","author":"Chen","year":"2000","journal-title":"Nat Med"},{"issue":"18","key":"10.1016\/j.bbr.2008.09.040_bib15","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.1832501100","article-title":"Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington\u2019s disease","volume":"100","author":"Wang","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.bbr.2008.09.040_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.10092","article-title":"Inhibition of autoimmune encephalomyelitis by a tetracycline","volume":"51","author":"Popovic","year":"2002","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.bbr.2008.09.040_bib17","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/sj.npp.1301377","article-title":"Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer\u2019s disease models","volume":"32","author":"Choi","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2008.09.040_bib18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.biopha.2007.12.005","article-title":"Does minocycline have antidepressant effect?","volume":"62","author":"Pae","year":"2008","journal-title":"Biomed Pharmacotherapy"},{"key":"10.1016\/j.bbr.2008.09.040_bib19","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1212\/01.WNL.0000125321.92112.7E","article-title":"Placebo-controlled phase I\/II studies of minocycline in amyotrophic lateral sclerosis","volume":"62","author":"Gordon","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2008.09.040_bib20","first-page":"80","article-title":"Host modulation with tetracyclines and their chemically modified analogues","volume":"2","author":"Golub","year":"1992","journal-title":"Curr Opin Dent"},{"key":"10.1016\/j.bbr.2008.09.040_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/08959374980120011901","article-title":"Chemical and biological dynamics of tetracyclines","volume":"12","author":"Nelson","year":"1998","journal-title":"Adv Den Res"},{"key":"10.1016\/j.bbr.2008.09.040_bib22","series-title":"Antibiotics and their complexes","first-page":"19","article-title":"Tetracyclines and daunorubicin in metal ions in biological system","author":"Martin","year":"1985"},{"issue":"3","key":"10.1016\/j.bbr.2008.09.040_bib23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0306-4522(03)00558-X","article-title":"Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection","volume":"121","author":"Dommergues","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2008.09.040_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0006-8993(01)02681-6","article-title":"Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum","volume":"909","author":"He","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2008.09.040_bib25","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/brain\/awf133","article-title":"Targeting leukocyte MMPs and transmigration minocycline as a potential therapy for multiple sclerosis","volume":"125","author":"Brundula","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2008.09.040_bib26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/35081571","article-title":"Metalloproteinases in biology and pathology of the nervous system","volume":"2","author":"Yong","year":"2001","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.bbr.2008.09.040_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.expneurol.2007.12.024","article-title":"Neuroprotective role of minocycline in co-cultures of human fetal neurons and microglia","volume":"211","author":"Filipovic","year":"2008","journal-title":"Exp Neurol"},{"issue":"3\u20134","key":"10.1016\/j.bbr.2008.09.040_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000113699","article-title":"Neuroinflammation in plaque and vascular beta-amyloid disorders: clinical and therapeutic implications","volume":"5","author":"Elkelenboom","year":"2008","journal-title":"Neurodegener Dis"},{"issue":"3","key":"10.1016\/j.bbr.2008.09.040_bib29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/85525","article-title":"Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy","volume":"7","author":"Bacskai","year":"2001","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.bbr.2008.09.040_bib30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.nbd.2007.07.019","article-title":"A limited role for microglia in antibody mediated plaque clearance in APP mice","volume":"28","author":"Garcia-Alloza","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"12","key":"10.1016\/j.bbr.2008.09.040_bib31","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.4049\/jimmunol.166.12.7527","article-title":"Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia","volume":"166","author":"Tikka","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.bbr.2008.09.040_bib32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","article-title":"In vivo measurement of activated microglia in dementia","volume":"358","author":"Cagnin","year":"2001","journal-title":"Lancet"},{"issue":"January (1)","key":"10.1016\/j.bbr.2008.09.040_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0002-9440(10)64354-4","article-title":"CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer\u2019s disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils","volume":"160","author":"Coraci","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bbr.2008.09.040_bib34","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMra022366","article-title":"Apoptosis and caspases in neurodegenerative diseases","volume":"348","author":"Robert","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbr.2008.09.040_bib35","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2741\/1357","article-title":"Apoptosis in acute and chronic neurological disorders","volume":"9","author":"Ekshyyan","year":"2004","journal-title":"Front Biosci"},{"issue":"9","key":"10.1016\/j.bbr.2008.09.040_bib36","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1523\/JNEUROSCI.5275-03.2004","article-title":"Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury","volume":"24","author":"Stirling","year":"2004","journal-title":"J Neurosci"},{"issue":"19","key":"10.1016\/j.bbr.2008.09.040_bib37","doi-asserted-by":"crossref","first-page":"19948","DOI":"10.1074\/jbc.M313629200","article-title":"Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria","volume":"279","author":"Wang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bbr.2008.09.040_bib38","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1073\/pnas.0306239101","article-title":"Minocycline inhibits contrusion\u2014triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury","volume":"101","author":"Teng","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2008.09.040_bib39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.nbd.2006.09.008","article-title":"Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline","volume":"25","author":"Mansson","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"8","key":"10.1016\/j.bbr.2008.09.040_bib40","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1523\/JNEUROSCI.21-08-02580.2001","article-title":"Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia","volume":"21","author":"Tikka","year":"2001","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.bbr.2008.09.040_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(01)02324-2","article-title":"Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons","volume":"315","author":"Lin","year":"2001","journal-title":"Neurosci Lett"},{"issue":"12","key":"10.1016\/j.bbr.2008.09.040_bib42","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1007\/s11064-007-9408-8","article-title":"p38alpha MAP kinase mediates hypoxia-induced motor neuron cell death: a potential target of minocycline\u2019s neuroprotective action","volume":"32","author":"Guo","year":"2007","journal-title":"Neurochem Res."},{"key":"10.1016\/j.bbr.2008.09.040_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12031-007-9011-0","article-title":"p38 Mitogen-activated protein kinase regulates myelination","volume":"35","author":"Haines","year":"2008","journal-title":"J Mol Neurosci"},{"issue":"16","key":"10.1016\/j.bbr.2008.09.040_bib44","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1038\/sj.onc.1207556","article-title":"Mitogen-activated protein kinases in apoptosis regulation","volume":"23","author":"Wada","year":"2004","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bbr.2008.09.040_bib45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jnr.10671","article-title":"Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult","volume":"73","author":"Piao","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bbr.2008.09.040_bib46","doi-asserted-by":"crossref","first-page":"15769","DOI":"10.1073\/pnas.95.26.15769","article-title":"Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia","volume":"95","author":"Yrjanheikki","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.bbr.2008.09.040_bib47","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.2967\/jnumed.107.041335","article-title":"Monitoring the protective effects of minocycline treatment with radiolabeled annexin V in an experimental model of focal cerebral ischemia","volume":"48","author":"Tang","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bbr.2008.09.040_bib48","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1471-4159.2007.05166.x","article-title":"Delayed combinatorial treatment with flavopiridol and minocycline provides longer term protection for neuronal soma but not dendrites following global ischemia","volume":"105","author":"Iyirhiaro","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2008.09.040_bib49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1179\/016164107X181824","article-title":"Hyperbaric oxygenation in peripheral nerve repair and regeneration","volume":"29","author":"Sanchez","year":"2007","journal-title":"Neurol Res"},{"key":"10.1016\/j.bbr.2008.09.040_bib50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.expneurol.2008.03.028","article-title":"Minocycline protects Schwann cells from ischemia-like injury and promotes axonal outgrowth in bioartificial nerve grafts lacking Wallerian degeneration","volume":"212","author":"Keilhoff","year":"2008","journal-title":"Exp Neruol"},{"key":"10.1016\/j.bbr.2008.09.040_bib51","first-page":"2580","article-title":"Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model","volume":"189","author":"Tusuji","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2008.09.040_bib52","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/0006-291X(92)91118-A","article-title":"Selective endothelial growth inhibition by tetracyclines that inhibit collagenase","volume":"188","author":"Guerin","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bbr.2008.09.040_bib53","first-page":"672","article-title":"Angiogenesis inhibition by minocycline","volume":"51","author":"Tamargo","year":"1991","journal-title":"Cancer Res"},{"issue":"14","key":"10.1016\/j.bbr.2008.09.040_bib54","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.wnl.0000277487.04281.db","article-title":"Minocycline treatment in acute stroke: an open-label, evaluator-blinded study","volume":"69","author":"Lampl","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2008.09.040_bib55","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.nbd.2006.10.022","article-title":"Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation","volume":"25","author":"Marier","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bbr.2008.09.040_bib56","first-page":"267","article-title":"Multiple sclerosis and chronic autoimmune encephalitis: a comparative quantative study of axonal injury in active, inactive, and remyelinated lesions","volume":"157","author":"Komek","year":"2000","journal-title":"Am H Pathol"},{"key":"10.1016\/j.bbr.2008.09.040_bib57","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transaction in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bbr.2008.09.040_bib58","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2249.1995.tb03864.x","article-title":"The influence of tetracyclines on T cell activation","volume":"102","author":"Kloppenburg","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.bbr.2008.09.040_bib59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jneuroim.2008.04.032","article-title":"Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients","volume":"197","author":"Ruggieri","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.bbr.2008.09.040_bib60","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/j.1471-4159.2006.03799.x","article-title":"Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury","volume":"97","author":"Festoff","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2008.09.040_bib61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.aje.a116933","article-title":"Epidemiology of traumatic spinal cord injury and acute hospitalization and rehabilitation charges for spinal cord injuries in Oklahoma, 1988\u201390","volume":"139","author":"Price","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bbr.2008.09.040_bib62","first-page":"S47","article-title":"Treatment of acute spinal cord injury with methylprednisole: results of a multicenter, randomized clinical trial","volume":"8","author":"Bracken","year":"1991","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.bbr.2008.09.040_bib63","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.sc.3100986","article-title":"High dose methylprednisolone in the management of acute spinal cord injury\u2014a systematic review from a clinical perspective","volume":"38","author":"Short","year":"2000","journal-title":"Spinal Cord"},{"key":"10.1016\/j.bbr.2008.09.040_bib64","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/11387","article-title":"Activation of the caspase-3 apoptotic cascadein traumatic spinal cord injury","volume":"5","author":"Springer","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.bbr.2008.09.040_bib65","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0197-0186(99)00133-3","article-title":"Cytokine chemikine expression in contused rat spinal cord","volume":"36","author":"Le","year":"2000","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bbr.2008.09.040_bib66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0079-6123(06)61015-7","article-title":"Update on the treatment of spinal cord injury","volume":"161","author":"Baptiste","year":"2007","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.bbr.2008.09.040_bib67","doi-asserted-by":"crossref","first-page":"7751","DOI":"10.1523\/JNEUROSCI.1661-07.2007","article-title":"Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury","volume":"27","author":"Yune","year":"2007","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.bbr.2008.09.040_bib68","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00001756-200206120-00018","article-title":"Minocycline delays onset and mortality in a transgenic model of ALS","volume":"13","author":"Bosch","year":"2002","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.bbr.2008.09.040_bib69","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/nbdi.2002.0487","article-title":"Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Kriz","year":"2002","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.bbr.2008.09.040_bib70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1212\/01.wnl.0000223353.34006.54","article-title":"Neuroprotective agents for clinical trials in ALS: a systematic assessment","volume":"67","author":"Traynor","year":"2006","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.bbr.2008.09.040_bib71","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","article-title":"Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial","author":"Gordon","year":"2007","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.bbr.2008.09.040_bib72","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ana.10614","article-title":"Minocycline and doxycycline are not beneficial in a model of Huntington\u2019s disease","volume":"54","author":"Smith","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2008.09.040_bib73","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbadis.2005.11.002","article-title":"Combination therapy using minocycline and coenzyme Q10 in R6\/2 transgenic Huntungton\u2019s disease mice","volume":"1762","author":"Stack","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.bbr.2008.09.040_bib74","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.bbr.2008.09.040_bib75","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.neuroscience.2006.05.043","article-title":"Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage and neuronal loss in an excitotoxic animal model of Huntington\u2019s disease","volume":"141","author":"Ryu","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2008.09.040_bib76","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington\u2019s disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2008.09.040_bib77","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00004850-200411000-00004","article-title":"Neuroprotection in Huntington\u2019s disease: a 2-year study on minocycline","volume":"19","author":"Bonelli","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.bbr.2008.09.040_bib78","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/01.WNL.0000049936.85487.7A","article-title":"Minocycline for Huntington\u2019s disease: an open label study","volume":"60","author":"Bonelli","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2008.09.040_bib79","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/mds.20018","article-title":"Minocycline in Huntington\u2019s disease: a pilot study","volume":"19","author":"Thomas","year":"2004","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.bbr.2008.09.040_bib80","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/mds.21199","article-title":"Revisiting safety of minocycline as neuroprotection in Huntington\u2019s disease","volume":"22","author":"Reynolds","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2008.09.040_bib81","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1471-4159.2006.03777.x","article-title":"Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline","volume":"97","author":"Casarejos","year":"2006","journal-title":"J Neurochem"},{"issue":"25","key":"10.1016\/j.bbr.2008.09.040_bib82","doi-asserted-by":"crossref","first-page":"14669","DOI":"10.1073\/pnas.251341998","article-title":"Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease","volume":"98","author":"Du","year":"2001","journal-title":"Proc Natl Acad Sci"},{"issue":"45","key":"10.1016\/j.bbr.2008.09.040_bib83","doi-asserted-by":"crossref","first-page":"11644","DOI":"10.1523\/JNEUROSCI.3447-06.2006","article-title":"Nigrostriatal dopaminergic neurodegeneration in the Weaver mouse is mediated via neuroinflammation and alleviated by minocycline administration","volume":"26","author":"Peng","year":"2006","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.bbr.2008.09.040_bib84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/WNF.0b013e3181342f32","article-title":"A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results","volume":"31","author":"Racette","year":"2008","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"10.1016\/j.bbr.2008.09.040_bib85","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer\u2019s disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.bbr.2008.09.040_bib86","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/pr.54.3.469","article-title":"Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer\u2019s disease","volume":"54","author":"Suh","year":"2002","journal-title":"Pharm Rev"},{"issue":"12","key":"10.1016\/j.bbr.2008.09.040_bib87","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1111\/j.0953-816X.2004.03439.x","article-title":"Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning","volume":"19","author":"Hunter","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2008.09.040_bib88","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/glia.20338","article-title":"Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice","volume":"53","author":"Seabrook","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.bbr.2008.09.040_bib89","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/glia.10153","article-title":"Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide","volume":"40","author":"Rogers","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.bbr.2008.09.040_bib90","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/glia.20268","article-title":"Inhibitory effect of minocycline on amyloid beta fibril formation and human microglial activation","volume":"53","author":"Familian","year":"2006","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.bbr.2008.09.040_bib91","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neulet.2007.01.052","article-title":"Minocycline does not affect amyloid beta phagocytosis by human microglial cells","volume":"416","author":"Familian","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2008.09.040_bib92","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/glia.20051","article-title":"Minocycline inhibits neuronal death and glial activationinduced by beta-amyloid peptide in rat hippocampus","volume":"48","author":"Ryu","year":"2004","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.bbr.2008.09.040_bib93","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.expneurol.2005.12.016","article-title":"Minocycline or iNOS inhibition block 3-nitrotyrosine increases and blood\u2013brain barrier leakiness in amyloid beta-peptide-injected rat hippocampus","volume":"198","author":"Ryu","year":"2006","journal-title":"Exp Neurol"},{"issue":"5544","key":"10.1016\/j.bbr.2008.09.040_bib94","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1126\/science.1067020","article-title":"The molecular biology of memory storage: a dialogue between genes and synapses","volume":"294","author":"Kandel","year":"2001","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bbr.2008.09.040_bib95","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1097-2765(00)00108-8","article-title":"Regulated translation initiation controls stress-induced gene expression in mammalian cells","volume":"6","author":"Harding","year":"2000","journal-title":"Mol Cell"},{"issue":"4","key":"10.1016\/j.bbr.2008.09.040_bib96","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0896-6273(03)00501-4","article-title":"Inducible enhancement of memory storage and synaptic plasticity in transgenic mice expressing an inhibitor of ATF4 (CREB-2) and C\/EBP proteins","volume":"39","author":"Chen","year":"2003","journal-title":"Neuron"},{"issue":"6716","key":"10.1016\/j.bbr.2008.09.040_bib97","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/16729","article-title":"Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase","volume":"397","author":"Harding","year":"1999","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbr.2008.09.040_bib98","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.neuroscience.2008.04.036","article-title":"Minocycline provides protection against \u03b2-amyloid (25-35) induced alterations of the somatostatin signaling pathway in the rat temporal cortex","volume":"154","author":"Burgos-Ramos","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2008.09.040_bib99","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/bmj.312.7024.169","article-title":"Minocycline-induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome","volume":"312","author":"Gough","year":"1996","journal-title":"Br Med J"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432808005500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432808005500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T13:09:36Z","timestamp":1557839376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432808005500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0166432808005500"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2008.09.040","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}